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OBJECTIVES The goal of this study was to determine the subcellular mechanism(s) underlying increased
left ventricular (LV) diastolic chamber stiffness (DCS) during angina (demand ischemia).
BACKGROUND Increased DCS may result from increased diastolic myocyte calcium concentration and/or
rigor. Therefore, we assessed the effects of direct alterations of both calcium-activated tension
and high-energy phosphates on increased DCS.
METHODS Demand ischemia was reproduced in isolated, isovolumic, red-cell perfused rabbit hearts by
imposing low-flow ischemia and pacing tachycardia. This resulted in increased DCS.
Interventions were performed after LV end-diastolic pressure had increased approximately
7 mm Hg. Initially, to determine the effects of altered calcium concentration or myofila-
ment calcium responsiveness, hearts received either: 1) 5 or 14 mmol/L calcium chloride;
2) 8 mmol/L egtazic acid; 3) 5 mmol/L butane-dione-monoxime (BDM); or 4) 50 mmol/L
ammonium chloride (NH4Cl). Then, to assess the contribution of decreased high-energy
phosphate supply, hearts received 5) glucose (25 mmol/L) and insulin (400 mU/ml).
RESULTS 1) Calcium chloride, 5 and 14 mmol/L, increased LV systolic pressure by 42% and 70%,
respectively (p , 0.001), indicating increased calcium-activated tension, but did not further
increase DCS, implying intact diastolic calcium resequestration. 2) Egtazic acid reduced LV
systolic pressure by 30% (p , 0.001), indicating reduced intracellular calcium, but failed to
reduce increased DCS. 3) Butane-dione-monoxime and NH4Cl chloride affected contractile
function (i.e., a calcium-driven force) but did not alter increased DCS. 4) Glucose and
insulin, which increase high-energy phosphates during ischemia, reduced increased DCS by
50% (p , 0.001).
CONCLUSIONS Increased DCS during demand ischemia was insensitive to maneuvers altering intracellular
calcium concentration or myofilament calcium-responsiveness, that is, evidence against an
etiology of calcium-activated tension. In contrast, increased glycolytic substrate ameliorated
increased DCS, supporting a primary mechanism of rigor-bond formation. (J Am Coll
Cardiol 2001;37:2144–53) © 2001 by the American College of Cardiology
Increased left ventricular (LV) diastolic chamber stiffness
occurs during angina (1,2). This is accompanied by reduced
lung compliance (3) with the clinical sequelae of chest con-
striction and, ultimately, pulmonary edema, as described by
Osler (4). Cytosolic calcium overload, with diastolic persistence
of calcium-activated cross-bridge cycling, and thus diastolic
myofilament tension generation, has been favored to be the
underlying mechanism (5,6). Alternatively, increased diastolic
tension also may result when adenosine triphosphate (ATP) is
reduced (7,8), possibly in conjunction with increased adenosine
diphosphate (9), resulting in failure of the actino-myosin
complex to dissociate during the cross-bridge cycle. Our
previous report, using quick-length changes in a model repro-
ducing the metabolic and mechanical diastolic pathophysiology
characteristic of angina, supported such a mechanism of
rigor-bond formation for increased diastolic stiffness (10).
Here, we used a different approach to characterize these
subcellular mechanism(s) further. We tested the hypothesis
that increased diastolic myofilament tension was not generated
by a calcium-mediated process, by directly assessing responses
to deliberate alterations of both calcium concentration, with
calcium and egtazic acid (EGTA), and myofilament calcium-
responsiveness, with butane-dione-monoxime (BDM) and
ammonium chloride (NH4Cl). To test for a rigor-mediated
mechanism due to disordered high-energy phosphate metab-
olism, we determined effects of increased glycolytic substrate,
which increases ATP and phosphocreatine concentrations
during ischemia (11).
The results provide additional evidence for a primary
mechanism involving rigor-bond formation, without any
component of calcium-mediated tension, as responsible for
the increased diastolic chamber stiffness observed during
demand ischemia, and they extend support for a therapeutic
role for glycolytic substrate.
METHODS
The model, utilizing isolated, balloon-in-LV erythrocyte-
perfused rabbit hearts has been described in detail previously
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(10). In each heart, baseline balloon volume was set to
achieve an LV end-diastolic pressure (LVEDP) of
20 mm Hg, and, thereafter, the volume was not changed
during the remainder of the experiment (i.e., each heart
contracted isovolumically). Thus, LV diastolic chamber
stiffness was indexed by LVEDP and LV contractility by
LV systolic or developed (i.e., systolic minus diastolic)
pressure and by the peak positive derivative of LV pressure
(1dP/dt). Ischemia was imposed by reducing coronary
blood flow to a constant rate, eliciting a coronary artery
perfusion pressure of 20 mm Hg, and, thereafter, flow was
not changed. After 5 min of ischemia, the demand ischemia
state was created by imposing tachycardia (7 Hz) during
continued restricted coronary blood flow. This resulted in a
progressive increase in LVEDP. Neither tachycardia alone
nor coronary flow restriction alone increased LVEDP; only
the combination (i.e., demand ischemia) increased LVEDP
(10). When LVEDP had increased approximately 7 mm Hg
above the pre-tachycardia value, tachycardia was terminated
(pacing rate was returned to 3 Hz), but coronary flow
continued at its constant, reduced rate for 5 min. In this
post-tachycardia hypoperfusion period, increased LVEDP
persisted, representing a state of stable increased diastolic
chamber stiffness resulting from increased metabolic de-
mand during low-flow perfusion. To determine the etiology
of increased stiffness, interventions were imposed after
tachycardia (i.e., in the presence of sustained ischemic
diastolic dysfunction). Tachycardia was terminated to
achieve a diastolic period of adequate length to ensure that
LVEDP was measured on the flat portion of the diastolic
pressure tracing (i.e., it reflected end-diastolic tension and
was not increased because of an inadequate time for com-
plete LV relaxation to occur).
Interventions. Hemodynamic function after tachycardia
during continued low-flow perfusion at a constant rate was
assessed for 5 min in a group of hearts receiving no
intervention (n 5 6). In others, interventional agents
(diluted in saline) were delivered directly into the coronary
circulation via aortic infusion. Agent infusion rates never
exceeded 5% of coronary flow. Concentrations are expressed
below as final arterial concentrations delivered.
Altered calcium availability. To test effects of deliberate
alterations of calcium concentration on increased diastolic
chamber stiffness, hearts received either calcium to increase
or EGTA to reduce intracellular calcium concentration.
Altering extracellular calcium concentration promptly alters
the intracellular calcium transient and contractile force,
simultaneously and proportionately (12,13). Left ventricular
contractile function, indexed by systolic or developed pres-
sure, is known to be generated by calcium-activated cross-
bridge cycling. Since the hearts contracted isovolumically
and preload was constant, any change in contractile function
upon exposure to calcium or EGTA represented an alter-
ation of calcium-mediated active tension. Hence, in these
experiments, alterations of LV contractile function were
used as an “internal control,” reflecting a calcium-
myofilament interaction, and were compared with simulta-
neous effects (if any) on increased isovolumic LVEDP to
assess whether this was similarly calcium-dependent.
Calcium. Hearts received a 1 min infusion of: 1) normal
saline (N Sal) (n 5 7), 2) 5 mmol/L calcium chloride
(Ca11) (5 mM, n 5 7) and 3) 14 mmol/L Ca11 (14 mM,
n 5 6). These infusions commenced immediately after
cessation of tachycardia.
EGTA. Hearts received a 1 min infusion of 8 mmol/L
EGTA 1.5 min after tachycardia was terminated (EGTA,
n 5 6). A post-tachycardia period of 1.5 min was selected
because, at this point, contractile function, depressed during
tachycardia, had recovered and stabilized, therefore allowing
manifestation of EGTA’s effect on contractile function.
Myofilament calcium-responsiveness was altered by
agents that do not affect intracellular calcium concentration
but manifest effects on myofilament calcium-sensitivity at
both systolic and diastolic levels of calcium (14). Again,
changes in isovolumic LV contractile function (dependent
on calcium-activated cross-bridge cycling) in response to
these interventions represented effects on contractility at the
myofilament level and provided an “internal control” to
compare with effects (if any) occurring on increased isovolu-
mic LVEDP.
NH4Cl. Since myofilament sensitivity to calcium is influ-
enced by intracellular pH, we used NH4Cl, which produces
intracellular alkalanization, followed by washout acidifica-
tion (14). We hypothesized that, if increased diastolic
stiffness was calcium-driven, then NH4Cl should exert a
biphasic effect on isovolumic LVEDP. Hearts received a
50 mmol/L infusion for 1 min commenced 1.5 min after
tachycardia (NH4Cl, n 5 7).
BDM. Butane-dione-monoxime reduces calcium-activated
cross-bridge cycling without altering the calcium transient
(at concentrations #5 mmol/L) (i.e., results in excitation-
contraction uncoupling and is incapable of breaking formed
rigor-bonds) (14,15). We reasoned that, if increased dia-
stolic stiffness due to demand ischemia resulted from per-
sistent calcium-activated tension, then this should be re-
duced by BDM. To test this, hearts received a 5 mmol/L
infusion for 5 min after tachycardia (BDM, n 5 8).
Abbreviations and Acronyms
ATP 5 adenosine triphosphate
BDM 5 butane-dione-monoxime
Ca11 5 calcium chloride
EGTA 5 egtazic acid
G 1 I 5 glucose and insulin
LV 5 left ventricle or left ventricular
LVEDP 5 left ventricular end-diastolic pressure
NH4Cl 5 ammonium chloride
N Sal 5 normal saline
1dP/dt 5 peak positive derivative of left ventricular
pressure
2dP/dt 5 peak negative derivative of left ventricular
pressure
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Increased glycolytic substrate. To test whether disordered
high-energy phosphate metabolism was responsible for
increased diastolic stiffness, hearts received high glucose
(25 mmol/L) and insulin (400 mU/ml) (G 1 I) for 5 min
after tachycardia (n 5 6). To control for the high osmolality
of this glycolytic substrate, a group of hearts received
25 mmol/L mannitol (n 5 6) for 5 min after tachycardia.
Data acquisition and statistical analysis. Pressure mea-
surements were recorded continuously. In individual hearts,
data are reported at six time points: baseline, 5 min after
imposition of ischemia and 0, 1.5, 3 and 5 min after
termination of tachycardia (mean 6 SEM). Statistical
comparisons between groups were performed by two-way
analysis of variance. If overall analysis of variance indicated
a significant difference of groups, trials or interaction, values
at specific time points were examined by the method of least
significant differences. A p value of ,0.05 was considered
significant.
All animal handling and procedures strictly complied
with the regulations of Boston University Animal Care and
the National Society for Medical Research.
RESULTS
Coronary flows and hemodynamics at baseline and before
intervention were similar in all groups (Tables 1 and 2). In
each heart, coronary flow and perfusion pressure remained
constant during ischemia and were unaffected by tachycardia
or by interventions. Hence, in our experiments, altered
isovolumic LVEDP in response to interventions indicated
an effect on diastolic stiffness without any confounding
contribution from altered coronary vascular turgor. Post-
tachycardia hemodynamic function did not differ between
hearts that received no intervention compared with those
that received N Sal (i.e., saline had no effect). In these,
contractile function recovered and stabilized within 90 s of
termination of tachycardia. Increased diastolic stiffness per-
sisted and did not increase further (isovolumic LVEDP: N
Sal, 0 vs. 5 min after tachycardia 5 25 6 1 vs. 27 6 1 mm
Hg, p 5 NS). This represented a state of stable ischemic
diastolic dysfunction during which interventions were per-
formed. Effects of interventions that used a saline vehicle are
compared with N Sal in Table 2.
Calcium. Increasing perfusate calcium level increased con-
tractile function, indicating a significant increase in intra-
cellular calcium; LV systolic pressure increased to 81 6
4 mm Hg in Ca11 5 mM and to 97 6 5 mm Hg in Ca11
14 mM groups compared with 57 6 3 mm Hg in the N Sal
group (p , 0.001) (Fig. 1). However, LVEDP was unaf-
fected by 5 mM Ca11 and significantly decreased by
14 mM Ca11. The rate of LV pressure decay (2dP/dt),
which had decreased with the onset of ischemia, further
decreased with tachycardia. However, both 5 mmol/L and
14 mmol/L of calcium significantly enhanced 2dP/dt.
EGTA reduced contractile function; LV systolic pressure
decreased by 30% to 42 6 5 mm Hg compared with 60 6
3 mm Hg in the N Sal group (p , 0.001), indicating
decreased intracellular calcium concentration (Fig. 2). How-
ever, there was no reduction of increased LVEDP.
Ammonium chloride elicited a biphasic response of contrac-
tile function: an initially positive, followed by a negative,
inotropic effect (Fig. 3). The peak positive inotropic effect
occurred 30 s after infusion, consistent with an initial alka-
lanization, where systolic pressure increased from 55 6 3 to
70 6 4 (p , 0.001), indicating enhanced myofilament
calcium-sensitivity, and was accompanied by increased 1dP/
dt. However, there was no concomitant change in increased
LVEDP. A negative inotropic effect then followed (during
“washout” acidification), where systolic pressure decreased
from 70 6 4 to 52 6 2 mm Hg (p , 0.001), indicating
diminished myofilament calcium-sensitivity but, again, with
no accompanying change in increased LVEDP.
Butane-dione-monoxime progressively reduced contrac-
tile function, consistent with its property of reducing
calcium-driven cross-bridge-cycling (Fig. 4). Left ventricu-
lar systolic pressure decreased from 60 6 2 to 55 6 2 (p ,
0.01 vs. N Sal). Developed pressure decreased by approxi-
mately 25%, from 31 6 3.4 to 23 6 2.6 mm Hg (p , 0.001)
at 5 min. However, increased LVEDP was not similarly
reduced (i.e., increased diastolic stiffness was not driven by
a calcium-mediated process).
Hence, interventions affecting calcium concentrations





Increase in LVEDP (mm Hg)Baseline Ischemia
N Sal (n 5 7) 1.05 6 0.08 0.34 6 0.04 14.6 6 1.8 7.0 6 0.4
Ca11 5 mM (n 5 7) 1.06 6 0.04 0.31 6 0.03 14.3 6 1.7 7.6 6 0.9
Ca11 14 mM (n 5 6) 1.06 6 0.12 0.33 6 0.03 15.8 6 3.8 8.4 6 1.3
EGTA (n 5 6) 0.98 6 0.06 0.32 6 0.02 16.1 6 1.4 6.4 6 0.4
NH4CL (n 5 7) 1.22 6 0.11 0.40 6 0.05 15.7 6 2.2 8.9 6 1.3
BDM (n 5 8) 1.05 6 0.03 0.34 6 0.01 15.3 6 0.9 7.3 6 0.3
G 1 I (n 5 6) 0.96 6 0.18 0.40 6 0.02 17.3 6 1.3 7.9 6 0.9
Mannitol (n 5 6) 1.00 6 0.07 0.37 6 0.04 13.0 6 1.6 7.7 6 0.6
BDM 5 hearts receiving 5 mmol/L butane-dione-monoxime; Ca11 5 mM 5 hearts receiving 5 mmol/L calcium; Ca11 14 mM 5 hearts receiving 14 mmol/L calcium; CBF 5
coronary blood flow; EGTA 5 hearts receiving 8 mmol/L egtazic acid; G 1 I 5 hearts receiving high glucose (25 mmol/L) and insulin (400 mU/ml); LVEDP 5 left ventricular
diastolic pressure; LVww 5 left ventricular wet weight; Mannitol 5 hearts receiving 25 mmol/L mannitol; NH4CL 5 hearts receiving 50 mmol/L ammonium chloride; N Sal 5
hearts receiving saline.
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directly, or its effects further “downstream” at the myofila-
ment level, failed to alter increased diastolic stiffness result-
ing from demand ischemia in the direction expected of a
calcium-dependent tension (in contrast with their effects on
contractility).
Increased glycolytic substrate. Glucose and insulin partially
reversed the ischemia-induced increase in diastolic chamber
stiffness; LVEDP declined from 25 6 1 to 22 6
1 mm Hg 5 min after infusion (p , 0.001) (i.e., toward
pre-tachycardia values [Fig. 5 and 6]). At 5 min after
infusion, LVEDP was 27 6 1 mm Hg in N Sal compared
with 22 6 1 mm Hg in G 1 I (p , 0.001). Since
LVEDP was approximately 18 mm Hg before tachycar-
dia in both groups, the effect of G 1 I represented an
amelioration of ischemic diastolic dysfunction of .50%
during this period. Glucose and insulin also enhanced
relaxation rate; 2dP/dt increased to 507 6 39 mm Hg/s
at 5 min (p , 0.02). Glucose and insulin did not
significantly affect LV systolic pressure. However, since
G 1 I progressively reduced LVEDP, there was an
accompanying increase in LV developed pressure. This
increased by 38% at 5 min (47 6 4 vs. 34 6 4 mm Hg in
N Sal, p , 0.01), and 1dP/dt increased to 616 6 51 (p ,
0.001) (i.e., a significant increase in contractile function).
The effects of G 1 I could not be explained by its high
osmolality since equiosmolar mannitol affected neither
systolic nor diastolic function (p 5 NS vs. N Sal). Figure
6 compares the positive inotropic and lusitropic effects of
G 1 I to equiosmotic mannitol.
DISCUSSION
Here, in a demand ischemia model simulating features of
angina, we demonstrated that increased diastolic tension
Table 2. Hemodynamic Effects of Interventions
Group Baseline Ischemia
Post-tachycardia (min)
0 1.5 3 5
LVSP (mm Hg)
N Sal 126 6 4 67 6 5 38 6 1 57 6 3 60 6 3 61 6 4
Ca11 5 mM 130 6 6 61 6 3 39 6 1 81 6 4* 69 6 3† 68 6 2\
Ca11 14 mM 119 6 6 67 6 2 43 6 2 97 6 5* 70 6 6* 68 6 4
EGTA 122 6 3 62 6 5 39 6 2 58 6 3 42 6 5* 51 6 5‡
NH4CL 123 6 3 58 6 3 39 6 1 55 6 3 70 6 4* 52 6 2*
BDM 120 6 6 63 6 3 42 6 2 60 6 2 59 6 2 55 6 2‡
G 1 I 122 6 10 65 6 4 46 6 4 63 6 4 69 6 4 69 6 4
Mannitol 117 6 4 57 6 2 37 6 3 53 6 3 57 6 4 59 6 4
LVEDP (mm Hg)
N Sal 20 18 6 0.4 25 6 1 25 6 1 26 6 1 27 6 1
Ca11 5 mM 20 16 6 0.5 23 6 1 22 6 1 23 6 2 24 6 2
Ca11 14 mM 20 17 6 1 24 6 1 21 6 1* 21 6 1* 23 6 1†
EGTA 20 16 6 1 23 6 1 24 6 2 26 6 2 30 6 3\
NH4CL 20 17 6 0.3 26 6 1 25 6 2 24 6 2 26 6 3
BDM 20 19 6 0.4 27 6 1 29 6 1 30 6 2 33 6 3
G 1 I 20 17 6 1 25 6 1 24 6 1 23 6 1* 22 6 1*
Mannitol 20 18 6 0.4 25 6 0.3 26 6 1 26 6 1 28 6 1
LV 1 dP/dt (mm Hg/s)
N Sal 1,286 6 69 546 6 58 182 6 8 332 6 25 382 6 29 395 6 36
Ca11 5 mM 1,534 6 108 587 6 39 251 6 31 787 6 66* 597 6 59* 566 6 57†
Ca11 14 mM 1,320 6 144 599 6 47 281 6 32 1,283 6 98* 724 6 114* 627 6 80‡
EGTA 1,372 6 58 605 6 70 269 6 48 413 6 65 204 6 60‡ 287 6 86
NH4CL 1,286 6 87 491 6 30 202 6 22 355 6 45 560 6 66† 305 6 36
BDM 1,267 6 110 573 6 36 236 6 22 390 6 38 370 6 30 293 6 32§
G 1 I 1,390 6 115 608 6 34 267 6 13 457 6 46‡ 567 6 43* 616 6 51*
Mannitol 1,225 6 86 556 6 40 223 6 25 391 6 59 445 6 55 451 6 59
LV 2 dP/dt (mm Hg/s)
N Sal 1,037 6 55 489 6 65 126 6 18 301 6 32 363 6 35 375 6 52
Ca11 5 mM 1,062 6 56 545 6 21 144 6 21 604 6 62* 442 6 31 449 6 34
Ca11 14 mM 1,014 6 86 599 6 58 192 6 20 949 6 77* 524 6 76\ 488 6 79
EGTA 956 6 33 563 6 75 187 6 45 329 6 44 133 6 42* 199 6 58†
NH4CL 1,011 6 71 446 6 38 111 6 17 294 6 42 425 6 54 240 6 31§
BDM 1,089 6 56 551 6 55 167 6 18 342 6 42 321 6 37 264 6 31\
G 1 I 1,020 6 78 563 6 59 147 6 25 356 6 31 455 6 29 507 6 39§
Mannitol 937 6 62 475 6 38 81 6 25 256 6 57 299 6 61 319 6 65
*p , 0.001; †p , 0.005; ‡p , 0.01; §p , 0.02; \p , 0.05 vs. N Sal.
BDM 5 hearts receiving 5 mmol/L butane-dione-monoxime; Ca11 5 mM 5 hearts receiving 5 mmol/L calcium; Ca11 14 mM 5 hearts receiving 14 mmol/L calcium;
EGTA 5 hearts receiving 8 mmol/L egtazic acid; G 1 I 5 hearts receiving high glucose (25 mmol/L) and insulin (400 mU/ml); LV 5 left ventricular; LV 1 dP/dt 5 peak
positive derivative of LV pressure; LV 2 dP/dt 5 peak negative derivative of LV pressure; LVEDP 5 LV diastolic pressure; LVSP 5 LV systolic pressure; Mannitol 5 hearts
receiving 25 mmol/L mannitol; NH4CL 5 hearts receiving 50 mmol/L ammonium chloride; N Sal 5 hearts receiving saline.
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was insensitive to alterations of either calcium concentration
or myofilament calcium-responsiveness but was responsive
to increased glycolytic substrate. This suggests that disor-
dered high-energy phosphate metabolism, without any
component of a calcium-mediated tension, is the mecha-
nism responsible for abnormal diastolic relaxation.
Angina/demand ischemia. The characteristic reduction in
diastolic distensibility during angina has been attributed to
persistent diastolic calcium (1,5,6), although this has not
been directly demonstrated. The demand ischemia that
characterizes angina may especially predispose to cytosolic
calcium overload since, not only can energy-dependent
calcium clearance mechanisms (resequestration by the sar-
coplasmic reticulum and transsarcolemmal efflux) be limited
by ischemia, but tachycardia results in repetitive depolariza-
tions with increased sodium and calcium entry per unit
time. Tachycardia simultaneously abbreviates the diastolic
period during which calcium reuptake and efflux occur.
Our experimental demand ischemia model replicated the
features of a patient with fixed coronary artery stenosis who
develops angina with increased myocardial oxygen demand
during tachycardia. Diastolic chamber stiffness increased
only when tachycardia was superimposed upon a state of
fixed moderate coronary flow reduction (but not with
tachycardia or ischemia alone) and was reversible when the
supply-demand mismatch was corrected (10). However, in
this model, the use of global (not regional) ischemia, though
imposing homogenous perfusion conditions throughout the
Figure 1. Calcium during demand ischemia. Ischemia (decreasing coronary perfusion pressure [CPP] to 20 mm Hg) reduced left ventricular systolic
pressure (LVSP) to 70 mm Hg and left ventricular end-diastolic pressure (LVEDP) to 13 mm Hg. Tachycardia increased isovolumic LVEDP to
20 mm Hg, indicating increased diastolic chamber stiffness. A 14 mmol/L calcium (14 mM Ca11) imposed after tachycardia during sustained ischemic
diastolic dysfunction increased LVSP from 60 to 110 mm Hg, indicating increased intracellular calcium concentration. However, LVEDP did not
simultaneously increase (but in this example decreased from 20 to 18 mm Hg), suggesting that during ischemic diastolic dysfunction, calcium
resequestration mechanisms remained intact and that the upward shift in LVEDP during tachycardia was not calcium-driven. Left ventricular systolic
pressure recovered subsequent to infusion.
Figure 2. Egtazic acid (EGTA) during demand ischemia. Ischemia (decreasing coronary perfusion pressure [CPP] to 20 mm Hg) reduced left ventricular
systolic pressure (LVSP) to 68 mm Hg and left ventricular end-diastolic pressure (LVEDP) to 15 mm Hg. Tachycardia increased LVEDP to 21 mm Hg,
indicating increased diastolic chamber stiffness. An 8 mmol/L EGTA (8 mM) imposed after tachycardia during sustained ischemic diastolic dysfunction
reduced LVSP from 70 to 48 mm Hg, indicating reduced intracellular calcium concentration but did not decrease elevated LVEDP, suggesting that this
was not calcium-driven. Contractile function recovered after termination of EGTA.
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heart and facilitating mechanistic determination, resulted in
a degree of contractile dysfunction not observed clinically
unless there is accompanying three-vessel disease.
Lack of a role for calcium. Despite the hypothetical
predilection for calcium overload during demand ischemia,
our results demonstrated no evidence for such a state
occurring in this model. Neither deliberate alterations of
calcium availability (increasing perfusate calcium concentra-
tion or adding EGTA to the perfusate) nor alteration of
myofilament calcium-responsiveness (with BDM or
NH4Cl) had any effect on increased diastolic stiffness in the
direction expected of a calcium-mediated tension. In strik-
ing contrast, all of these interventions markedly affected LV
contractile function, demonstrating that these interventions
achieved their intended intracellular action on calcium-
activated cross-bridge cycling and, hence, calcium-activated
tension. Thus, the calcium dependence and sensitivity of
systolic active tension was illustrated but clearly dissociated
Figure 3. Ammonium chloride (NH4Cl) during demand ischemia. Ischemia (decreasing coronary perfusion pressure [CPP] to 20 mm Hg) reduced left
ventricular systolic pressure (LVSP) to 60 mm Hg and left ventricular end-diastolic pressure (LVEDP) to 18 mm Hg. Tachycardia increased LVEDP to
25 mm Hg, indicating increased diastolic chamber stiffness. 50 mmol/L ammonium chloride (50 mM NH4Cl) imposed after tachycardia during sustained
ischemic diastolic dysfunction initially increased LVSP from 63 to 80 mm Hg, then reduced it to 56 mm Hg, indicating a positive, followed by a negative,
inotropic effect, consistent with its known effects on intracellular pH and, hence, myofilament calcium-sensitivity. Elevated LVEDP, however, remained
unchanged, implying that it was not increased by a calcium-activated mechanism.
Figure 4. Butane-dione-monoxime (BDM) during demand ischemia. Ischemia (decreasing coronary perfusion pressure [CPP] to 20 mm Hg) reduced left
ventricular systolic pressure (LVSP) to 62 mm Hg and left ventricular end-diastolic pressure (LVEDP) to 18 mm Hg. Tachycardia increased LVEDP to
28 mm Hg, indicating increased diastolic chamber stiffness. A 5 mmol/L BDM (5 mM) infusion imposed after tachycardia during sustained ischemic
diastolic dysfunction progressively decreased LVSP from 62 to 43 mm Hg, indicating inhibition of calcium-activated myofilament cross-bridge cycling.
However, elevated LVEDP was not simultaneously decreased, suggesting that it was not calcium-driven. Contractile function recovered after termination
of infusion.
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from the calcium independence and insensitivity of the
persistently elevated diastolic tension. Hence, increased
diastolic calcium did not appear to be a direct determinant
of increased diastolic chamber stiffness. Furthermore, since
deliberate calcium loading failed to drive a further increase
in increased diastolic stiffness, we inferred that myocyte
calcium resequestration/efflux mechanisms were able to
accommodate this exogenously imposed load (i.e., were not
functionally limited during this ischemic state).
The brevity of the test infusions of calcium (and EGTA)
during ischemic diastolic dysfunction was a deliberate ex-
perimental design feature. Prolonged infusions may have
confounded our conclusions. For example, we demonstrated
preserved calcium resequestration capacity and lack of a
direct relation of calcium-activated tension to increased
stiffness by assessing the immediate, qualitative effects of
brief alterations of calcium concentrations. Importantly,
calcium loading was not used to test absolute calcium
resequestration capacity. A more concentrated or prolonged
calcium challenge may have ultimately driven an increase in
diastolic stiffness (i.e., a response to an overwhelming
exogenous calcium load), saturating diastolic clearance
mechanisms. Notably, we did not reach this state even with
14 mmol/L calcium, a load sufficient to more than double
contractile function. Additionally, a sustained increase in
contractile work with prolonged calcium exposure during
continued ischemia may have secondarily reduced ATP
level, confounding interpretation of underlying mecha-
nisms. Conversely, prolonged EGTA exposure may have
increased ATP due to reduced contractile work. For exam-
ple, if a sustained calcium infusion had increased LVEDP
after a prolonged period of increased contractility, we would
have been unable to distinguish a mechanism of a direct
effect of calcium (i.e., calcium-activated tension) from in-
creased rigor-bond formation, secondary to ATP depletion,
as the mechanism underlying increased diastolic stiffness.
Hence, the brevity of interventions was critical and served to
assess the contribution of calcium-mediated tension to
diastolic stiffness at the moment of intervention, while
minimizing the possibility of secondary perturbation of
high-energy phosphate metabolism.
Prior studies have demonstrated that increased diastolic
calcium occurs during ischemia, hypoxia or metabolic inhi-
bition (16,17), attributed to a combination of increased
calcium influx, reduced efflux and diminished sarcoplasmic
reticulum uptake. Although this seems to support a
calcium-driven mechanism for ischemic diastolic dysfunc-
tion, others have reported a dissociation between the relative
time course of increased myocyte calcium and the develop-
ment of contracture (18). In one study, increased diastolic
force preceded a rise in intracellular calcium (19) (and
correlated better with reduced ATP). Thus, there may be no
cause-effect relationship between the observation during
ischemia of increased diastolic calcium concentration and
increased diastolic tension. Our prior report suggests that
diastolic calcium assessed by calcium indicators may not, in
any case, accurately reflect myofilament-bound calcium
(13). In contrast with previous studies, here we created the
specific condition of demand ischemia and then assessed
responses to interventions during established diastolic dys-
function to test the postulated relation of calcium to
increased diastolic tension. Our results, however, supported
no causative role for diastolic calcium-driven cross-bridge
cycling as the responsible mechanism.
Figure 5. Increased glycolytic substrate during demand ischemia. Ischemia (decreasing coronary perfusion pressure [CPP] to 20 mm Hg) reduced left
ventricular systolic pressure (LVSP) to 55 mm Hg and left ventricular end-diastolic pressure (LVEDP) to 16 mm Hg. Tachycardia increased LVEDP to
24 mm Hg, indicating increased diastolic chamber stiffness. High 25 mmol/L glucose (25 mM) and insulin (400 mU/ml) infusion gradually increased LVSP,
and concomitantly decreased LVEDP from 24 to 18 mm Hg (i.e., reversed the increase in LV diastolic chamber stiffness produced by demand ischemia),
toward pre-tachycardia values.
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The mechanisms underlying diastolic dysfunction during
the specific pathophysiology of demand ischemia have
received comparatively little study. One report, in a pacing-
tachycardia canine model with a fixed coronary artery
stenosis, observed that caffeine administered during the last
30 s of tachycardia exacerbated the extent of diastolic
dysfunction (6). In the present study, we instead used
deliberate calcium loading, which is a purer challenge than
caffeine (which produces sarcoplasmic reticulum dysfunc-
tion), after LVEDP had increased during demand ischemia.
In contrast with results with caffeine, we could not drive a
further increase in increased diastolic stiffness with this
maneuver, suggesting that calcium resequestration ability
had remained intact during demand ischemia, despite the
increase in LVEDP.
Rigor-bond formation. Glucose and insulin ameliorated
diastolic dysfunction resulting from demand ischemia. Pos-
sibly, a more prolonged exposure to glycolytic substrate (i.e.,
longer than the 5 min used in this study) would have totally
reversed the increased chamber stiffness sustained during
demand ischemia. Increasing glycolytic substrate during
ischemia markedly enhances glycolytically derived ATP,
increases ATP and phosphocreatine concentration and
ameliorates diastolic dysfunction (11). Hypothetically, in-
creased ATP may serve to increase calcium resequestration
by ion pumps (e.g., sarcoplasmic reticular calcium-ATPase)
limited by reduced energy supply during ischemia and/or act
directly at the myofilament level. Since we demonstrated no
evidence for disabled myocardial calcium resequestration
during ischemic diastolic dysfunction, we infer that in-
creased ATP, generated by increased glycolytic flux, en-
hanced relaxation directly by facilitating actino-myosin
cross-bridge detachment (i.e., reversal of the actino-myosin
“rigor complex” that forms in the cross-bridge cycle). Such
a mechanism is consistent with our prior results where
quick-length changes during demand ischemia elicited re-
sponses characteristic of rigor (10).
Myocyte heterogeneity. The development of locked cross-
bridges in a minority of myocytes is a possible explanation
for our results. During ischemic diastolic dysfunction, two
populations of myocytes may coexist. Those in rigor, inex-
citable and incapable of developing contractile force (15),
increase diastolic pressure in proportion to their number but
remain unresponsive to the alteration of calcium availability
Figure 6. Summary of hemodynamic effects of increased glycolytic substrate during demand ischemia, contrasted with equiosmotic mannitol. Groups were
similar before intervention. Tachycardia (7 Hz) imposed during ischemia increased diastolic stiffness (isovolumic left ventricular end-diastolic pressure
[LVEDP]). Glucose 25 mmol/L and insulin 400 mU/ml (G 1 I) progressively reduced increased diastolic stiffness and enhanced contractile function (left
ventricular developed pressure [LV Dev P]). Mannitol had no effect.
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or sensitivity. Myocytes not in rigor contract actively and
generate phasic LV pressures but remain responsive to
perturbations of calcium availability and sensitivity, manifest
as alterations in contractile function. Since 5 mmol/L
calcium, EGTA, BDM or NH4Cl failed to affect elevated
LVEDP after tachycardia, these ischemic, but contracting,
myocytes do not seem to contribute a calcium-activated
component to diastolic tension. Reversal of contracture,
observed when, for example, anoxic myocytes are reoxygen-
ated (18), manifests in the whole heart when the supply-
demand mismatch is corrected or in response to glycolytic
substrate, or quick-length changes (10).
Although we did not directly demonstrate intermyocyte
heterogeneity in these experiments, such a concept is sup-
ported by several studies. During demand ischemia, the
subendocardium is especially vulnerable to ischemia (20).
Similarly, 31P NMR studies of isolated hearts subjected to
global low-flow ischemia identified two regions with differ-
ing degrees of acidosis, and the extent of increase in
LVEDP correlated closely with the size of the more severely
acidotic (presumably subendocardial) region (21). Isolated
cardiomyocytes subjected to metabolic inhibition have dem-
onstrated a variable time onset to rigor (22), and ultrastruc-
tural studies of isolated hearts subjected to global low-flow
ischemia have illustrated some myocytes in rigor juxtaposed
to cells with near-normal ultrastructure (23).
High-energy phosphates. Ischemic contracture in hearts
subjected to zero-flow ischemia coincides with reduced
ATP (7). However, in the current model, when LVEDP
had increased 10 mm Hg during demand ischemia, we
demonstrated no reduction in ATP beyond that attributable
to the low-flow ischemic state alone (10). However, demand
ischemia may represent a less extreme condition and not
analogous to experimental states of either zero-flow isch-
emia or prolonged metabolic inhibition (in which irrevers-
ible contracture and cell death ensues relatively rapidly in all
myocytes). In our model, coronary flow was only moderately
reduced and myocyte function preserved manifest by con-
tinued systolic function, albeit at a reduced level
(“perfusion-contraction matching”). A reversible increase in
LVEDP, observed only after metabolic demand was in-
creased during reduced perfusion, required for elicitation a
critical combination of reduced coronary perfusion pressure
and flow, achieved only with a red-cell perfusate at 37°C.
This condition may represent a subtle ischemic state where
only an increased workload reveals myocytes more vulnera-
ble to developing rigor, the number of which progressively
increases during continued supply-demand mismatch. Un-
der such conditions, estimations of total tissue ATP may
not reveal a critical ATP reduction in only the minority of
myocytes that have developed locked cross-bridges. Addi-
tionally, during ischemia, ATP content does not reflect
ATP turnover rate, which may better index the degree of
energetic failure. Conversely, improvement of mechanical
function during ischemia with increased glycolytic substrate,
though associated with markedly enhanced glycolytic ATP
flux, does not dramatically alter total ATP content (11).
Ramifications of the study. The study demonstrates fur-
ther characteristics of actino-myosin interactions. Although
rigor is typically illustrated by irreversible contracture oc-
curring, for example, during prolonged zero-flow ischemia
when there is severe ATP depletion (“stone heart”) (7), our
results suggest that, under selected conditions, the initial
phases of the rigor process may be potentially reversible.
Normally, an actino-myosin “rigor-complex” forms during
the cross-bridge cycle, and detachment requires ATP bind-
ing to the high affinity site on the myosin head and is critical
for achieving diastolic relaxation. During demand ischemia,
when high-energy phosphate supply may be limiting despite
continued myocardial perfusion, some myocytes may arrest
in the rigor-phase of the cross-bridge cycle but can resume
normal function when ATP supply is increased by correc-
tion of the supply-demand mismatch (10) or by provision of
glycolytic substrate. Glycolytically derived ATP, therefore,
facilitates myofilament relaxation independently of effects
on cytosolic calcium homeostasis. This may be the mecha-
nism underlying the beneficial effect of high glucose and
insulin observed clinically in acute coronary syndromes (24)
and experimentally where it blunted the degree of ischemic
diastolic dysfunction sustained during prolonged underper-
fusion, simulating conditions of cardiogenic shock (11). In
this study, we also demonstrated the ability to reverse rigor
after it had occurred (with a concomitant inotropic action).
Demand ischemia, classically observed during exercise-
induced angina, may also occur during unstable angina or
during myocardial infarction, when regions of myocardium
are subjected to the combination of moderately reduced
perfusion and increased metabolic demand. Therefore, our
result further supports the use of glycolytic substrate as
adjunctive therapy for acute coronary syndromes (24).
Study limitations. We did not measure intracellular pH,
calcium or calcium-sensitivity in response to agents admin-
istered in the perfusate. However, exposure to calcium,
NH4Cl and BDM in the concentrations we used translates
into the intended intracellular actions at the myofilament
level, and these have been well characterized by others
(12,14,15). Additionally, since only moderately reduced
perfusion was imposed on hearts thus preserving active
contraction, we inferred intracellular actions from changes
in LV contractile pressure (i.e., a known calcium-dependent
force) as an “internal control,” to compare with diastolic
pressure. We did not measure the effect of glycolytic
substrate on high-energy phosphates, but this has been
characterized previously in isolated hearts subjected to
reduced perfusion conditions (11).
Summary. Our results are inconsistent with a mechanism
of calcium-driven tension as the cause of the increased
diastolic tension during demand ischemia, but they support
a mechanism of rigor-bond formation that is ameliorated by
glycolytic substrate.
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